Influenza Antiviral Drugs Market 2028 By Type, Treatment Type, Mechanism of Action, Vaccine Type, Routes of Administration, End Users and Geography | The Insight Partners

report image

Influenza Antiviral Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Influenza A, Influenza B, Influenza C); Treatment Type (Medication, Chemoprophylaxis, Others); Mechanism of Action (Cap- dependent endonuclease inhibitor, Nuraminidase Inhibitor, Matrix-2 Protein Inhibitor, Viral Uncoatings Inhibitors, Immunomodulators); Vaccine Type (Quadrivalent, Trivalent ,Others); Routes of Administration (Oral, Parenteral, Others); End Users (Hospitals, Clinics, Specialty Clinics, Others) and Geography

Report Code: TIPRE00015600 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming


Influenza is a kind of viral infection which has a contagious nature that causes a upper respiratory tract infection and affects nose, throat as well as lungs. The symptoms usually starts from mild nature but can be life threatening it not treated in time. The more prone to infection are the people who have a weakened immune system or having age above 65 years. The symptoms of influenza includes, sweat, chills, sore throat, fever. The major category of drugs which are used in treatment of influenza include, antiviral and immunomodulatory agents.


The key market drivers for Influenza Antiviral Drugs Market Includes, increasing prevalence of influenza infection worldwide along with introduction of novel drug therapies and various treatment options are some factors which will drive market during the forecast period. However, high cost of treatment, expiration of patents and launching of generic drugs are some factors which will hamper market growth during the forecast period.


The "Influenza Antiviral Drugs Market" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Influenza Antiviral Drugs market with detailed market segmentation by type, treatment type, mechanism of action, vaccine type, route of administration, and end user. The Influenza Antiviral Drugs Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Influenza Antiviral Drugs Market and offers key trends and opportunities in the market.


The Influenza Antiviral Drugs Market is segmented on the basis of type, treatment type, mechanism of action, vaccine type, route of administration, and end user. On the basis of type the market is segmented into, influenza, Influenza B, and Influenza C. On the basis of treatment type it is segmented as, medication, chemoprophylaxis and others. On the basis of mechanism of action the market is segmented as, cap- dependent endonuclease inhibitor,nuraminidase inhibitor, matrix-2 protein inhibitor. On the basis of vaccine type quadrivalent, trivalent and others. On the basis of route of administration the market is segmented as, oral, parenteral and others. And on the basis of end user the market is segmented as, hospitals, clinics, and others.


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Influenza Antiviral Drugs Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Influenza Antiviral Drugs Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Influenza Antiviral Drugs Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Influenza Antiviral Drugs Market in these regions.

Get more information on this report :


The report covers key developments in the Influenza Antiviral Drugs Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Influenza Antiviral Drugs Market are anticipated to have lucrative growth opportunities in the future with the rising demand for Aortic and Peripheral Vascular Interventional Therapy Product, market in the global market. Below mentioned is the list of few companies engaged in the Influenza Antiviral Drugs Market.

The report also includes the profiles of key players in Influenza Antiviral Drugs Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.

  •   Sun Pharmaceuticals Industries, Ltd
  •   ADMA Biologics,Inc
  •   Shionogi Inc
  •   F. Hoffmann-La Roche Ltd
  •   Cipla Inc
  •   Glaxosmithkline Plc
  •   Teva Pharmaceutical Industries Ltd
  •   Novartis AG
  •   Sanofi
  •   AstraZeneca

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Get more information on this report :

The List of Companies

1. Sun Pharmaceutical Industries Ltd
2. ADMA Biologics, Inc
3. Shionogi Inc
4. F. Hoffmann-La Roche Ltd
5. Cipla Inc
6. GlaxoSmithKline Plc
7. Teva Pharmaceutical Industries Ltd
8. Novartis AG
9. Sanofi
10. AstraZeneca
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount